scholarly article | Q13442814 |
P50 | author | Melanie G Cree | Q60345817 |
P2093 | author name string | Mark Brown | |
Laura Z Fenton | |||
Jacob E Friedman | |||
Zhaoxing Pan | |||
Ann Scherzinger | |||
Linda A Barbour | |||
Meredith Alston | |||
Regina Reynolds | |||
David E Brumbaugh | |||
Camille Hoffman | |||
Phillip Tearse | |||
P2860 | cites work | Prevalence and trends in obesity among US adults, 1999-2008 | Q29547759 |
Physical water compartments: a revised concept of perinatal body water physiology | Q30990401 | ||
Cord blood lipid profile and associated factors: baseline data of a birth cohort study | Q31133140 | ||
Assessment of in vivo 1H magnetic resonance spectroscopy in the liver: a review | Q31147355 | ||
Maternal overweight programs insulin and adiponectin signaling in the offspring. | Q33874488 | ||
Lipid metabolism in the fetus and the newborn | Q33950662 | ||
Offspring of mothers fed a high fat diet display hepatic cell cycle inhibition and associated changes in gene expression and DNA methylation. | Q33968085 | ||
Criteria for screening tests for gestational diabetes | Q34057052 | ||
Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus | Q34399314 | ||
Magnetic resonance imaging of total body fat. | Q34478709 | ||
Long-term impact of neonatal breastfeeding on childhood adiposity and fat distribution among children exposed to diabetes in utero | Q34583303 | ||
Quantitative comparison and evaluation of software packages for assessment of abdominal adipose tissue distribution by magnetic resonance imaging. | Q34987278 | ||
Continuous glucose profiles in obese and normal-weight pregnant women on a controlled diet: metabolic determinants of fetal growth | Q35225493 | ||
Pediatric obesity phenotyping by magnetic resonance methods | Q35846444 | ||
Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study | Q35879112 | ||
Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. | Q36842095 | ||
Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates | Q37073698 | ||
Obesity and the placenta: A consideration of nutrient exchange mechanisms in relation to aberrant fetal growth. | Q37804549 | ||
Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population | Q39693472 | ||
Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in mice | Q43088513 | ||
Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance | Q45192290 | ||
Maternal diabetes and perinatal programming | Q46333328 | ||
Independent effect of visceral adipose tissue on metabolic syndrome in obese adolescents | Q46584914 | ||
Nonalcoholic fatty liver disease and carotid atherosclerosis in children | Q46689926 | ||
Weight gain recommendations in pregnancy and the obesity epidemic | Q47579331 | ||
Differential growth of fetal tissues during the second half of pregnancy | Q48811470 | ||
Body composition from birth to 4.5 months in infants born to non-obese women. | Q51574558 | ||
Maternal high-fat feeding primes steatohepatitis in adult mice offspring, involving mitochondrial dysfunction and altered lipogenesis gene expression. | Q51610482 | ||
Resistance to high-fat diet in the female progeny of obese mice fed a control diet during the periconceptual, gestation, and lactation periods. | Q51773758 | ||
Role of lipids and fatty acids in macrosomic offspring of diabetic pregnancy. | Q51972536 | ||
I. Using the Bland–Altman method to measure agreement with repeated measures | Q60706382 | ||
The Human Visceral Fat Depot Has a Unique Inflammatory Profile | Q61774862 | ||
Estimation of adipose tissue mass by magnetic resonance imaging: validation against dissection in human cadavers | Q72879987 | ||
Distribution of adipose tissue in the newborn | Q75185464 | ||
Fast and reproducible method for the direct quantitation of adipose tissue in newborn infants | Q77728136 | ||
Body-composition assessment in infancy: air-displacement plethysmography compared with a reference 4-compartment model | Q79512510 | ||
The influence of maternal body mass index on infant adiposity and hepatic lipid content | Q84237518 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | obesity | Q12174 |
gestational diabetes | Q126691 | ||
P304 | page(s) | 930-6.e1 | |
P577 | publication date | 2012-12-20 | |
P1433 | published in | The Journal of Pediatrics | Q7743611 |
P1476 | title | Intrahepatic fat is increased in the neonatal offspring of obese women with gestational diabetes | |
P478 | volume | 162 |
Q89360925 | A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes |
Q60301299 | A long-term maternal diet transition from high-fat diet to normal fat diet during pre-pregnancy avoids adipose tissue inflammation in next generation |
Q30386847 | Association of maternal diabetes/glycosuria and pre-pregnancy body mass index with offspring indicators of non-alcoholic fatty liver disease. |
Q60923925 | Childhood Fructoholism and Fructoholic Liver Disease |
Q100467626 | Developmental Programming of NAFLD by Parental Obesity |
Q41459686 | Developmental Programming of Nonalcoholic Fatty Liver Disease: The Effect of Early Life Nutrition on Susceptibility and Disease Severity in Later Life. |
Q57786921 | Developmental Programming of Obesity and Diabetes in Mouse, Monkey, and Man in 2018: Where Are We Headed? |
Q30241940 | Developmental origins of NAFLD: a womb with a clue |
Q33844787 | Developmental origins of nonalcoholic fatty liver disease |
Q37149656 | Developmental programming of pediatric nonalcoholic fatty liver disease: redefining the"first hit". |
Q37600179 | Diabetes in pregnancy and infant adiposity: systematic review and meta-analysis. |
Q47868552 | Early Microbes Modify Immune System Development and Metabolic Homeostasis-The "Restaurant" Hypothesis Revisited |
Q36231960 | Early PQQ supplementation has persistent long-term protective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice |
Q37737481 | Early infant adipose deposition is positively associated with the n-6 to n-3 fatty acid ratio in human milk independent of maternal BMI. |
Q33959776 | Early life exposure to maternal insulin resistance has persistent effects on hepatic NAFLD in juvenile nonhuman primates |
Q39006023 | Early life programming and the risk of non-alcoholic fatty liver disease |
Q33938664 | Effect of maternal obesity with and without gestational diabetes on offspring subcutaneous and preperitoneal adipose tissue development from birth up to year-1. |
Q36355537 | Emerging Technologies and their Applications in Lipid Compartment Measurement |
Q91929324 | Excessive early-life cholesterol exposure may have later-life consequences for nonalcoholic fatty liver disease |
Q47766573 | Fetal Overnutrition and Adolescent Hepatic Fat Fraction: the Exploring Perinatal Outcomes in Children Study. |
Q90004538 | Free-breathing 3-D quantification of infant body composition and hepatic fat using a stack-of-radial magnetic resonance imaging technique |
Q50147806 | Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. |
Q38170410 | Gestational diabetes mellitus and cardiovascular risk after pregnancy. |
Q92759281 | Implications of Nonalcoholic Fatty Liver Disease on Pregnancy and Maternal and Child Outcomes |
Q36422562 | Increased placental fatty acid transporter 6 and binding protein 3 expression and fetal liver lipid accumulation in a mouse model of obesity in pregnancy |
Q38352166 | Influence of maternal overnutrition and gestational diabetes on the programming of metabolic health outcomes in the offspring: experimental evidence |
Q92567501 | Liver Diseases in the Perinatal Period: Interactions Between Mother and Infant |
Q40263336 | Low and High Birth Weights Are Risk Factors for Nonalcoholic Fatty Liver Disease in Children. |
Q90399714 | Maternal Fat-1 Transgene Protects Offspring from Excess Weight Gain, Oxidative Stress, and Reduced Fatty Acid Oxidation in Response to High-Fat Diet |
Q91592451 | Maternal Lipids and Fetal Overgrowth: Making Fat from Fat |
Q88621894 | Maternal Non-glycemic Contributors to Fetal Growth in Obesity and Gestational Diabetes: Spotlight on Lipids |
Q91556029 | Maternal body mass index, gestational weight gain, and childhood abdominal, pericardial, and liver fat assessed by magnetic resonance imaging |
Q45810128 | Maternal obesity alters fatty acid oxidation, AMPK activity, and associated DNA methylation in mesenchymal stem cells from human infants |
Q38413839 | Maternal obesity characterized by gestational diabetes increases the susceptibility of rat offspring to hepatic steatosis via a disrupted liver metabolome. |
Q35050191 | Maternal obesity influences the relationship between location of neonate fat mass and total fat mass |
Q37118107 | Maternal sodium butyrate supplement elevates the lipolysis in adipose tissue and leads to lipid accumulation in offspring liver of weaning-age rats |
Q90213353 | Metabolic Culprits in Obese Pregnancies and Gestational Diabetes Mellitus: Big Babies, Big Twists, Big Picture : The 2018 Norbert Freinkel Award Lecture |
Q64987782 | Mice exposed to maternal androgen excess and diet-induced obesity have altered phosphorylation of catechol-O-methyltransferase in the placenta and fetal liver. |
Q35914082 | Microbial transmission from mothers with obesity or diabetes to infants: an innovative opportunity to interrupt a vicious cycle |
Q51287371 | Non-Alcoholic Fatty Liver Disease in Early Pregnancy Predicts Dysglycemia in Mid-Pregnancy: Prospective Study. |
Q27006992 | Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age? |
Q33789868 | Non-alcoholic fatty liver disease: An expanded review |
Q57802817 | Normalizing adiponectin levels in obese pregnant mice prevents adverse metabolic outcomes in offspring |
Q53693108 | Nutrition therapy within and beyond gestational diabetes. |
Q50204614 | Obesity in Pregnancy: Optimizing Outcomes for Mom and Baby |
Q37125762 | Obesity, maternal smoking and SHBG in neonates |
Q35019764 | On the origin of pediatric nonalcoholic Fatty liver disease. |
Q36115938 | Optimizing Weight for Maternal and Infant Health - Tenable, or Too Late? |
Q33831717 | Pediatric Non-Alcoholic Fatty Liver Disease |
Q89580537 | Physical exercise and liver "fitness": Role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver disease |
Q89185215 | Postprandial Triglycerides Predict Newborn Fat More Strongly than Glucose in Women with Obesity in Early Pregnancy |
Q49980187 | Quantification of fetal organ volume and fat deposition following in utero exposure to maternal Western Diet using MRI. |
Q50942572 | Radiographic depiction of intra-abdominal fat in newborns: a marker of infants born to diabetic mothers. |
Q92513941 | Reduced size at birth and persisting reductions in adiposity in recent, compared with earlier, cohorts of infants born to mothers with gestational diabetes mellitus |
Q99587158 | Seeing the fetus from a DOHaD perspective: discussion paper from the advanced imaging techniques of DOHaD applications workshop held at the 2019 DOHaD World Congress |
Q38589455 | Striking differences in estimates of infant adiposity by new and old DXA software, PEAPOD and skin-folds at 2 weeks and 1 year of life |
Q58548367 | Switching obese mothers to a healthy diet improves fetal hypoxemia, hepatic metabolites, and lipotoxicity in non-human primates |
Q92712205 | The Liver in Children With Metabolic Syndrome |
Q36792850 | The Progression and Natural History of Pediatric Nonalcoholic Fatty Liver Disease. |
Q58726261 | The Role of Long Non-Coding RNAs (lncRNAs) in the Development and Progression of Fibrosis Associated with Nonalcoholic Fatty Liver Disease (NAFLD) |
Q58115572 | The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD |
Q50318508 | The role of NAFLD in cardiometabolic disease: an update. |
Q92298443 | Transgenerational impact of maternal obesogenic diet on offspring bile acid homeostasis and nonalcoholic fatty liver disease |
Q34795140 | Transgenic increase in N-3/n-6 Fatty Acid ratio reduces maternal obesity-associated inflammation and limits adverse developmental programming in mice |
Q91406319 | Understanding susceptibility and targeting treatment in non-alcoholic fatty liver disease in children; moving the fulcrum |
Search more.